Zhejiang Xianju Pharmaceutical Co Ltd
Zhejiang Xianju Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid raw materials and preparations in China and internationally. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progestero… Read more
Market Cap & Net Worth: Zhejiang Xianju Pharmaceutical Co Ltd (002332)
Zhejiang Xianju Pharmaceutical Co Ltd (SHE:002332) has a market capitalization of $1.23 Billion (CN¥9.01 Billion) as of March 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #7477 globally and #1273 in its home market, demonstrating a 0.55% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang Xianju Pharmaceutical Co Ltd's stock price CN¥9.11 by its total outstanding shares 989204866 (989.20 Million).
Zhejiang Xianju Pharmaceutical Co Ltd Market Cap History: 2015 to 2026
Zhejiang Xianju Pharmaceutical Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $1.20 Billion to $1.23 Billion (1.71% CAGR).
Zhejiang Xianju Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang Xianju Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.33x
Zhejiang Xianju Pharmaceutical Co Ltd's market cap is 0.33 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
3.37x
Zhejiang Xianju Pharmaceutical Co Ltd's market cap is 3.37 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.20 Billion | $2.48 Billion | $106.55 Million | 0.48x | 11.22x |
| 2016 | $1.03 Billion | $2.50 Billion | $146.19 Million | 0.41x | 7.02x |
| 2017 | $984.72 Million | $2.85 Billion | $206.63 Million | 0.35x | 4.77x |
| 2018 | $743.67 Million | $3.62 Billion | $301.36 Million | 0.21x | 2.47x |
| 2019 | $1.21 Billion | $3.71 Billion | $410.37 Million | 0.33x | 2.95x |
| 2020 | $1.65 Billion | $4.02 Billion | $504.51 Million | 0.41x | 3.27x |
| 2021 | $1.65 Billion | $4.36 Billion | $619.33 Million | 0.38x | 2.66x |
| 2022 | $1.46 Billion | $4.38 Billion | $749.41 Million | 0.33x | 1.94x |
| 2023 | $1.68 Billion | $4.12 Billion | $563.08 Million | 0.41x | 2.98x |
| 2024 | $1.34 Billion | $4.00 Billion | $397.18 Million | 0.33x | 3.37x |
Competitor Companies of 002332 by Market Capitalization
Companies near Zhejiang Xianju Pharmaceutical Co Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Zhejiang Xianju Pharmaceutical Co Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Zhejiang Xianju Pharmaceutical Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Zhejiang Xianju Pharmaceutical Co Ltd's market cap moved from $1.20 Billion to $ 1.23 Billion, with a yearly change of 1.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.23 Billion | +1.11% |
| 2025 | CN¥1.21 Billion | -9.36% |
| 2024 | CN¥1.34 Billion | -20.23% |
| 2023 | CN¥1.68 Billion | +15.33% |
| 2022 | CN¥1.46 Billion | -11.50% |
| 2021 | CN¥1.65 Billion | -0.08% |
| 2020 | CN¥1.65 Billion | +36.26% |
| 2019 | CN¥1.21 Billion | +62.56% |
| 2018 | CN¥743.67 Million | -24.48% |
| 2017 | CN¥984.72 Million | -4.02% |
| 2016 | CN¥1.03 Billion | -14.20% |
| 2015 | CN¥1.20 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Zhejiang Xianju Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.23 Billion USD |
| MoneyControl | $1.23 Billion USD |
| MarketWatch | $1.23 Billion USD |
| marketcap.company | $1.23 Billion USD |
| Reuters | $1.23 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.